635 related articles for article (PubMed ID: 15601443)
21. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
Vuolteenaho K; Moilanen T; Moilanen E
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats.
Sidhu PK; Landoni MF; Lees P
Res Vet Sci; 2006 Feb; 80(1):79-90. PubMed ID: 16005916
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
24. A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog.
Toutain PL; Cester CC; Haak T; Laroute V
J Vet Pharmacol Ther; 2001 Feb; 24(1):43-55. PubMed ID: 11348486
[TBL] [Abstract][Full Text] [Related]
25. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid.
Delavenne X; Laporte S; Demasles S; Mallouk N; Basset T; Tod M; Girard P; Mismetti P
Fundam Clin Pharmacol; 2009 Feb; 23(1):127-35. PubMed ID: 19267776
[TBL] [Abstract][Full Text] [Related]
26. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
27. In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study.
Schmid VB; Seewald W; Lees P; King JN
J Vet Pharmacol Ther; 2010 Oct; 33(5):444-52. PubMed ID: 20840388
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline administered alone and in combination with carprofen in calves.
Brentnall C; Cheng Z; McKellar QA; Lees P
Res Vet Sci; 2013 Jun; 94(3):687-94. PubMed ID: 23415880
[TBL] [Abstract][Full Text] [Related]
29. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
Gabrielsson J; Green AR
J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
Fosslien E
Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.
Landoni MF; Lees P
Equine Vet J; 1995 Jul; 27(4):247-56. PubMed ID: 8536660
[TBL] [Abstract][Full Text] [Related]
32. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
[TBL] [Abstract][Full Text] [Related]
33. Effect of nimesulide-a preferential COX-2 inhibitor on arterial blood pressure, compared to ketoprofen.
Saran T; Sodolski W; Sodolska K; Danilkiewicz WC; Schabowski J
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):261-7. PubMed ID: 16146090
[TBL] [Abstract][Full Text] [Related]
34. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
35. Interpreting culture and susceptibility data in critical care: perks and pitfalls.
Boothe DM
J Vet Emerg Crit Care (San Antonio); 2010 Feb; 20(1):110-31. PubMed ID: 20230440
[TBL] [Abstract][Full Text] [Related]
36. Indirect pharmacodynamic response models do not require any parametric pharmacokinetic model to be fitted to effect-time data.
Piotrovsky VK
Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):723-9. PubMed ID: 9542723
[TBL] [Abstract][Full Text] [Related]
37. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs.
Kay-Mugford P; Benn SJ; LaMarre J; Conlon P
Am J Vet Res; 2000 Jul; 61(7):802-10. PubMed ID: 10895904
[TBL] [Abstract][Full Text] [Related]
38. Determination of a dosage regimen of colistin by pharmacokinetic/pharmacodynamic integration and modeling for treatment of G.I.T. disease in pigs.
Guyonnet J; Manco B; Baduel L; Kaltsatos V; Aliabadi MH; Lees P
Res Vet Sci; 2010 Apr; 88(2):307-14. PubMed ID: 19945722
[TBL] [Abstract][Full Text] [Related]
39. Oral cocaine pharmacokinetics and pharmacodynamics in a cumulative-dose regimen: pharmacokinetic-pharmacodynamic modeling of concurrent operant and spontaneous behavior within an operant context.
Lau CE; Sun L; Wang Q; Simpao A; Falk JL
J Pharmacol Exp Ther; 2000 Nov; 295(2):634-43. PubMed ID: 11046099
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and dosage regimens of anti-inflammatory drugs.
Lees P; May SA; White D
Ann Rech Vet; 1990; 21 Suppl 1():73S-78S. PubMed ID: 2080850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
